You are here

Africa

J&J booster slashes Omicron hospitalisations -South African study

Johnson & Johnson's booster shot provides high levels of protection against the omicron variant of Covid-19, according to data from a trial of healthcare workers in South Africa released Thursday.

Preliminary results from the Sisonke study, which have not been peer-reviewed, found that for people who had received one vaccine dose, the booster improved protection against hospitalization to 85 percent from 63 percent.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Testing for Omicron may need re-evaluation--South African study

If confirmed in follow-up research and if the diagnostics industry can pivot quickly enough, findings from a South African study could make COVID-19 testing a lot easier for patients and healthcare workers, as the SARS-CoV-2 Omicron variant becomes the dominant source of infection.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Africa
howdy folks
Page loaded in 0.825 seconds.